湖北成立首家知识产权直投机构，首轮投资“会思考的心脏”

Core Viewpoint - The establishment of Wuhan Guanggu Intellectual Property Investment Co., Ltd. marks the first intellectual property direct investment institution in Hubei, focusing on early-stage transformation of high-value intellectual property projects, with its first investment directed towards the innovative "AI artificial heart" technology [1][3]. Group 1: Intellectual Property Investment - Wuhan Guanggu Intellectual Property Investment Co., Ltd. is the first institution in Hubei dedicated to direct investment in intellectual property [1]. - The institution aims to evaluate, invest in, and support projects based on the value of their intellectual property, particularly targeting "early, small, and hard" projects [1][3]. - The establishment aligns with national efforts to integrate intellectual property with financial capital, indicating a trend towards more such institutions [1]. Group 2: AI Artificial Heart Technology - The "AI artificial heart" was developed by Wuhan Xinjing Medical Technology Co., Ltd., led by Professor Tao Liang, who has nearly 40 years of experience and has achieved over 20 original results in the field [1][2]. - The AI artificial heart can pump 7 liters of blood per minute, meeting the needs of a normal adult, and addresses critical conditions such as severe heart failure and cardiac arrest [2]. - The technology is still in the iterative upgrade phase, and early recognition from investment institutions is crucial for the growth of startups and original projects [2]. Group 3: Ecosystem Development - The collaboration between Guanggu Intellectual Property Investment and Xinjing Medical aims to create a "tropical rainforest" style innovation ecosystem in Hubei Wuhan, promoting the integration of technology and capital [3]. - This partnership is expected to provide new pathways for guiding financial capital towards high-tech industries [3].